ISSN: 1301-2193 E-ISSN: 1308-9846
  • Turkish Journal of
    Endocrinology and Metabolism
ORIGINAL ARTICLE

Migraine is Strongly Associated with Central Obesity Than with General Obesity: A Case-Control Study
Migren Genel Obeziteden Daha Fazla ve Güçlü Şekilde Santral Obezite ile İlişkilidir: Bir Vaka-Kontrol Çalışması
Doi: 10.25179/tjem.2018-63282 - Makale Dili: EN
Turk J Endocrinol Metab 2019;23:25-32
ABSTRACT
Objective: Obesity and migraine are common diseases worldwide, but their association is not confirmed. If an association is proved, weight loss can be made a management objective of a migraine. To assess the risk of migraines in Iraqi patients with general obesity and central obesity. Material and Methods: A case-control, hospital-based study was conducted at Al-Nuaman Teaching Hospital, Baghdad, Iraq from February 2017 to September 2017. One hundred - forty Iraqi patients were enrolled, including 50 patients with migraines and 90 controls without any migraine. General obesity and central obesity were assessed by examining the body mass index and waist-to-height ratio, respectively. Results: There is a significant association between migraines and general obesity and between migraines and central obesity (p<0.001, odds Ratio: general obesity 6.8, central obesity 12.2). Conclusion: The risk of migraines in patients with central obesity is double the risk in patients with general obesity.
ÖZET
Amaç: Obezite ve migren dünya çapında yaygın hastalıklardır, ancak birliktelikleri doğrulanmamıştır. Eğer birliktelikleri kanıtlanırsa, kilo kaybı migren yönetiminde hedef hâline gelebilmektedir. Bu çalışmada, genel ve santral obezitesi olan Irak’lı hastalarda migren riskinin değerlendirilmesi amaçlanmıştır. Gereç ve Yöntemler: Şubat 2017-Eylül 2017 arasında, Al-Nuaman Eğitim Hastanesinde (Bağdat, Irak) vaka-kontrolü, hastane-tabanlı bir çalışma yürütülmüştür. Çalışmaya, 50’si migrenli, 90’ı migrensiz olan (kontrol) 140 Irak’lı hasta dahil edilmiştir. Genel ve santral obezite sırasıyla beden kitle indeksi ve bel-boy oranı incelenerek değerlendirilmiştir. Bulgular: Migren ile genel ve santral obezite arasında anlamlı bir ilişki bulunmaktadır (p<0,001, Odds oranı: genel obezite 6,8, santral obezite 12,2). Sonuç: Santral obezitesi olan hastalarda migren riskinin genel obezitesi olan hastalardan iki kat fazla olduğu bulunmuştur.
KAYNAKLAR
  1. Goadsby PJ, Lipton RB, Ferrari MD. Migraine-current understanding and treatment. N Engl J Med. 2002;346:257-270. [Crossref]  [PubMed]
  2. Goadsby PJ.  Headache. In: Hankey  GJ, Wardlaw  JM, Gorelick PB,  Testai FD, eds.  Hankey’s Clinical Neu- rology (2nd ed).  Boca Raton; CRC  Press; 2014;139. [Crossref]
  3. Lipton RB,  Stewart WF,  Simon D. Medical consulta- tion for migraine:  results from the  American Mi- graine  Study. Headache. 1998;38:87-96.  [Crossref]  [PubMed]
  4. Smetana GW. The diagnostic value of historical fea- tures in primary headache syndromes: a compre- hensive review. Arch Intern Med. 2000;160:2729- 2737. [Crossref]  [PubMed]
  5. Wöber  C, Brannath  W, Schmidt  K, Kapitan  M, Rudel  E, Wessely  P,  Wöber-Bingöl C.  Prospective  analysis of  fac- tors  related to  migraine  attacks: The  PAMINA  study. Cephalalgia.  2007;27:304-314. [Crossref]   [PubMed]
  6. Spierings EL, Ranke AH, Honkoop PC. Precipitating and aggravating factors of migraine versus tension- type headache. Headache. 2001;41:554-558. [Crossref]  [PubMed]
  7. Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007;27:394-402. [Crossref]  [PubMed]
  8. Bigal ME, Lipton RB, Holland PR, Goadsby PJ. Obe- sity,  migraine, and chronic migraine: possible mechanisms of interaction. Neurology. 2007;68:1851- 1861. [Crossref]  [PubMed]
  9. Overeem S, van Vliet JA, Lammers GJ, Zitman FG, Swaab DF,  Ferrari MD. The hypothalamus in episodic brain disorders. Lancet Neurol. 2002;1:437-444. [Crossref]
  10. Keith SW, Wang C, Fontaine KR, Cowan CD, Allison DB. BMI and headache among women: results from 11 epidemiologic datasets. Obesity (Silver Spring). 2008;16:377-383. [Crossref]  [PubMed]
  11. Vo M, Ainalem A, Qiu C, Peterlin BL, Aurora SK, Williams MA. Body mass index and adult weight gain among reproductive age women with migraine. Headache. 2011;51:559-560. [Crossref]  [PubMed]
  12. Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology. 2006;66:545-550. [Crossref]  [PubMed]
  13. Bigal ME,  Lipton RB. Obesity  is a risk  factor for transformed migraine  but not chronic  tension-type headache. Neurology.  2006;67:252-257. [Crossref]  [PubMed]
  14. Bigal ME, Tsang  A, Loder E, Serrano  D, Reed ML, Lipton RB.  Body mass index and  episodic headaches: a population-based  study. Arch  Intern Med. 2007;167:1964-1970. [Crossref]   [PubMed]
  15. Ashwell M, Cole TJ, Dixon AK. Ratio of waist circumference to height is strong predictor of intra-ab- dominal fat. BMJ. 1996;313:559-560. [Crossref]  [PubMed]  [PMC]
  16. Goadsby PJ. Heasdache. In: Long DL, Kasper DL, Hauser SL, et al, eds. Harrison’s Neurology in Clinical Medicine (3rd ed). New York: McGraw-Hill Pub- lishing; 2013;56.
  17. Goadsby PJ. Heasdache. In: Long DL, Kasper DL, Hauser SL, et al, eds. Harrison’s Neurology in Clinical Medicine (3rd ed): New York: McGraw-Hill Pub- lishing; 2013;52.
  18. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev. 1994;74:761-811. [Cros- sref]  [PubMed]
  19. Wajchenberg BL, Giannella-Neto D, da Silva ME, Santos RF. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res. 2002;34:616-621. [Crossref]   [PubMed]
  20. Dieudonné MN, Leneveu MC, Giudicelli Y,  Pecquery R. Evidence for functional estrogen receptors alpha and beta in human adipose cells: regional speci- ficities and regulation by estrogens. Am J Physiol Cell Physiol. 2004;286:C655-C661. [Crossref]  [PubMed]
  21. Elert J,  Kendall SA, Larsson  B, Månsson B,  Gerdle B. Chronic pain and difficulty in relaxing postural muscles in patients with fibromyalgia and chronic whiplash associated disorders. J Rheumatol. 2001;28:1361-1368. [PubMed]
  22. Okifuji A, Bradshaw DH, Olson C. Evaluating obesity in fibromyalgia: neuroendocrine biomarkers, symptoms, and functions. Clin Rheumatol. 2009;28:475-478. [Crossref]  [PubMed] [PMC]
  23. Lee S, Kim TN, Kim SH. Sarcopenic obesity is more closely associated with knee osteoarthritis than is nonsarcopenic obesity: a cross-sectional study. Arthritis Rheum. 2012;64:3947-3954. [Crossref]   [PubMed]
  24. Lee R, Kean WF. Obesity and knee osteoarthritis. In- flammopharmacology. 2012;20:53-58. [Crossref]  [PubMed]
  25. Eslick GD. Gastrointestinal symptoms and obesity: a meta-analysis. Obes Rev. 2012;13:469-479.  [Crossref]  [PubMed]
  26. Bilal Natiq Nuaman. The association between cen- tral obesity and the risk of irritable bowel syndrome: a case-control study. American Journal of Medical Sciences and Medicine. 2017;5:23-26. http://pubs.sciepub.com/ajmsm/5/2/1.  [Crossref]
  27. Fransen M, Woodward  M, Norton R, Coggan  C, Dawe M, Sheridan  N. Risk factors associated  with the transition from  acute to chronic occupational  pain. Spine (Phila Pa  1976). 2002;27:92-98.[Crossref]
  28. Chen BD,  Yang YN,  Ma YT,  Pan S, He  CH, Liu  F, Ma X, Fu  ZY, Li  XM, Xie X,  Zheng YY.  Waist-to-height ratio and triglycerides/high-density  lipoprotein cho- lesterol were  the optimal predictors  of metabolic syndrome in  Uighur men and  women in Xinjiang, China. Metab Syndr  Relat Disord. 2015;13:214-220. [Crossref]  [PubMed]
  29. Scher AI,  Stewart WF,  Ricci JA, Lipton  RB. Factors associated with  the onset and  remission of chronic daily headache in  a population-based  study. Pain. 2003;106:81-89. [Crossref]
  30. Peres MF,  Lerário DD, Garrido AB, Zukerman E. Primary headaches in obese patients. Arq Neuropsiquiatr. 2005;63:931-933. [Crossref]   [PubMed]
  31. Gelber  RP, Gaziano JM,  Orav EJ, Manson  JE, Bur- ing JE,  Kurth T.  Measures of  obesity and  cardio- vascular risk  among men and  women. J Am  Coll Cardiol.  2008;52:605-615. [Crossref]   [PubMed]  [PMC]
  32. Hershey AD, Powers SW, Nelson TD, Kabbouche MA, Winner P, Yonker M, Linder SL, Bicknese A, Sowel MK, McClintock W. Obesity in the pediatric headache population: a multicenter study. Headache. 2009;49:170-177. [Crossref]  [PubMed]
  33. Kinik ST, Alehan F, Erol I, Kanra AR. Obesity and paediatric migraine. Cephalalgia. 2010;30:105-109. [Crossref]  [PubMed]
  34. Pinhas-Hamiel O, Frumin K, Gabis L, Mazor- Aronovich K, Modan-Moses D, Reichman B, Lerner- Geva L. Headaches in overweight children and adolescents referred to a tertiary-care center in Israel. Obesity (Silver Spring). 2008;16:659-663. [Crossref]  [PubMed]
  35. Horev A, Wirguin I, Lantsberg L, Ifergane G. A high incidence of migraine with aura among mor- bidly obese women. Headache. 2005;45:936-938. [Crossref]  [PubMed]
  36. Yu  S, Liu R,  Yang X,  Zhao G, Qiao  X, Feng J,  Fang Y, Cao X, He  M, Steiner TJ.  Body mass index  and mi- graine: a  survey of the  Chinese adult population.  J Headache Pain. 2012;13:531-536.  [Crossref]  [Pub - Med]  [PMC]
  37. Vo M, Ainalem A, Qiu C, Peterlin BL, Aurora SK, Williams MA. Body mass index and adult weight gain among reproductive age women with migraine. Headache. 2011;51:559-569. [Crossref]  [PubMed]  [PMC]
  38. Winter AC, Berger K, Buring JE, Kurth T. Body mass index, migraine, migraine frequency and migraine features in women. Cephalalgia. 2009;29:269-278. [Crossref]  [PubMed]  [PMC]
  39. Mattsson P. Migraine headache and obesity in women aged 40-74 years: a population-based study. Cephalalgia. 2007;27:877-880. [Crossref]  [PubMed]
  40. Queiroz  LP, Peres  MF,  Piovesan EJ,  Kowacs  F, Ciciarelli  MC, Souza  JA,  Zukerman E. A  nationwide  population- based study of  migraine in Brazil.  Cephalalgia. 2009;29:642-649. [Crossref]   [PubMed]
  41. Ford ES, Li C, Pearson WS, Zhao G, Strine TW, Mok- dad AH. Body mass index and headaches: findings from a national sample of US adults. Cephalalgia. 2008;28: 1270-1276. [Crossref]  [PubMed]
  42. Peterlin BL,  Rosso AL, Rapoport  AM, Scher AI.  Obe- sity and  migraine: the effect  of age, gender  and adi- pose tissue  distribution. Headache. 2010;50:52-62.  [Crossref]  [PubMed]   [PMC]
  43. Rossoni de Oliveira V, Camboim Rockett F, Castro K, da Silveira Perla A, Chaves ML, Schweigert Perry ID. Body mass index, abdominal obesity, body fat and migraine features in women. Nutr Hosp. 2013;28: 1115-1120. [PubMed]
  44. Sadeghi O,  Askari G, Maghsoudi  Z, Ghiasvand R, Khorvash F.  The association between  abdominal obesity and characteristics  of migraine attacks  in Iranian adults. Iran  J Nurs Midwifery  Res. 2016;21: 271-277. [Crossref]   [PubMed]   [PMC]
  45. Verrotti A,  Agostinelli S, D’Egidio  C, Di Fonzo  A, Carotenuto M, Parisi  P, Esposito  M, Tozzi  E, Belcas- tro  V, Mohn A,  Battistella PA.  Impact of a  weight loss program on  migraine in obese  adolescents. Eur J Neurol. 2013;20:394-397. [Crossref]   [PubMed]
  46. Zhang ZQ, Deng J, He LP, Ling WH, Su YX, Chen YM. Comparison of various anthropometric and body fat indices in identifying cardiometabolic disturbances in Chinese men and women. PLoS One. 2013;8: e70893. [Crossref]  [PubMed]  [PMC]
  47. Jayawardana R, Ranasinghe  P, Sheriff MH, Matthews DR, Katulanda P. Waist to height ratio: a better an- thropometric marker of diabetes and cardio meta- bolic risks in South Asian adults. Diabetes Res Clin Pract. 2013;99:292-299. [Crossref]  [PubMed]
  48. Miri A, Nasiri M, Zonoori S, Yarahmad F, Dab- bagh-Moghadam A, Askari G, Sadeghi O, Asadi M. The association between obesity and migraine in a population of Iranian adults: a case-control study. Diabetes Metab Syndr. 2018;12:733-736.  [Crossref]  [PubMed]
  49. 49 Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharma AM, Anand SS. Obesity and the risk of my- ocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366: 1640-1649. [Crossref]
  50. Wang  Y, Rimm EB,  Stampfer MJ, Willet  WC, Hu FB. Comparison of abdominal  adiposity and overall  obe- sity in predicting  risk of type  2 diabetes among men. Am J  Clin Nutr.  2005;81:555-563. [Crossref]  [PubMed]
  51. Tietjen GE,  Peterlin BL, Brandes  JL, Hafeez  F, Hutchinson S, Martin  VT, Dafer  RM, Aurora  SK, Stein MR, Herial  NA, Utley C,  White L, Khuder  SA. De- pression and  anxiety: effect on  the migraine-obe- sity relationship.  Headache. 2007;47:866-875. [Crossref]  [PubMed]
  52. Duarte H,  Teixeira AL, Rocha  NP, Domingues  RB. Increased serum levels  of adiponectin in  migraine. J Neurol Sci.  2014;342:186-188. [Crossref]  [PubMed]
  53. Rozen T, Swidan SZ. Elevation of CSF tumor necro- sis factor alpha levels in new daily persistent headache and treatment refractory chronic mi- graine. Headache. 2007;47:1050-1055. [Crossref]  [PubMed]
  54. Edvinsson L, Goadsby PJ. Neuropeptides in migraine headache. Cephalalgia. 1994;14:320-327. [Crossref]  [PubMed]
  55. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cere- brovascular and neuropeptide changes seen in humans and cats. Ann Neurol. 1993;33:48-56.  [Crossref]  [PubMed]
  56. Blundel  JE, Halford  JCG.  Serotonin and  appetite  regu- lation:  implications  for the  pharmacological  treatment of obesity.  CNS  Drugs. 1998;9:473-495.  [Crossref]
  57. Sarchielli P,  Rainero I, Coppola F, Rossi C, Mancini M, Pinessi L, Calabresi P. Involvement of corti- cotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: find- ings from cerebrospinal fluid. Cephalalgia. 2008;28:714-722. [Crossref]  [PubMed]
  58. Bond DS,  Vithiananthan S, Nash  JM, Thomas JG, Wing RR. Improvement  of migraine headaches  in severely obese patients after bariatric surgery. Neu- rology. 2011;76:1135-1138. [Crossref]  [PubMed] [PMC]
  59. Novack V, Fuchs L, Lantsberg L, Kama S, Lahoud U, Horev A, Loewenthal N, Ifergane G. Changes in headache frequency in premenopausal obese women with migraine after bariatric surgery: a case series. Cephalalgia. 2011;31:1336-1342. [Crossref]  [PubMed]
  60. Bond DS,  O’Leary KC, Thomas  JG, Lipton RB,  Pa- pandonatos GD, Roth  J, Rathier L,  Daniello R, Wing RR. Can weight  loss improve migraine  headaches in obese women?  Rationale and  design of the  Women’s Health and  Mingraine (WHAM) randomized  controlled trial. Contemp  Clin Trials.  2013;35:133-144. [Crossref]  [PubMed]  [PMC]